关注
Alex Spyropoulos
Alex Spyropoulos
Professor of Medicine, Hematology/Thrombosis
在 northwell.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
circulation 129 (3), e28-e292, 2014
167322014
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European …
Authors/Task Force Members, SV Konstantinides, A Torbicki, G Agnelli, ...
European heart journal 35 (43), 3033-3080, 2014
44352014
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
Journal of the American college of cardiology 75 (23), 2950-2973, 2020
33802020
Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …
JD Douketis, AC Spyropoulos, FA Spencer, M Mayr, AK Jaffer, ...
Chest 141 (2), e326S-e350S, 2012
20142012
Perioperative bridging anticoagulation in patients with atrial fibrillation
JD Douketis, AC Spyropoulos, S Kaatz, RC Becker, JA Caprini, AS Dunn, ...
New England Journal of Medicine 373 (9), 823-833, 2015
12772015
The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines
JD Douketis, PB Berger, AS Dunn, AK Jaffer, AC Spyropoulos, RC Becker, ...
Chest 133 (6), 299S-339S, 2008
11802008
Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients …
S Kaatz, D Ahmad, AC Spyropoulos, S Schulman
Journal of Thrombosis and Haemostasis 13 (11), 2119-2126, 2015
8712015
Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with …
AC Spyropoulos, JH Levy, W Ageno, JM Connors, BJ Hunt, T Iba, M Levi, ...
Journal of Thrombosis and Haemostasis 18 (8), 1859-1865, 2020
7772020
Rivaroxaban for thromboprophylaxis in acutely ill medical patients
AT Cohen, TE Spiro, HR Büller, L Haskell, D Hu, R Hull, A Mebazaa, ...
New England Journal of Medicine 368 (6), 513-523, 2013
7362013
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism
VF Tapson, H Decousus, M Pini, BH Chong, JB Froehlich, M Monreal, ...
Chest 132 (3), 936-945, 2007
6282007
Predictive and associative models to identify hospitalized medical patients at risk for VTE
AC Spyropoulos, FA Anderson Jr, G FitzGerald, H Decousus, M Pini, ...
Chest 140 (3), 706-714, 2011
5772011
Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates
D Siegal, J Yudin, S Kaatz, JD Douketis, W Lim, AC Spyropoulos
Circulation 126 (13), 1630-1639, 2012
5432012
Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic …
S Kaatz, D Ahmad, AC Spyropoulos, S Schulman
J Thromb Haemost 13 (11), 2119-2126, 2015
5092015
How I treat anticoagulated patients undergoing an elective procedure or surgery
AC Spyropoulos, JD Douketis
Blood, The Journal of the American Society of Hematology 120 (15), 2954-2962, 2012
4792012
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators
H Decousus, VF Tapson, JF Bergmann, BH Chong, JB Froehlich, ...
Chest 139 (1), 69-79, 2011
4792011
Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19 …
AC Spyropoulos, M Goldin, D Giannis, W Diab, J Wang, S Khanijo, ...
JAMA internal medicine 181 (12), 1612-1620, 2021
4252021
Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or …
B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ...
J Am Coll Cardiol 75 (23), 2950-2973, 2020
4052020
Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations
AC Spyropoulos, J Lin
Journal of Managed Care Pharmacy 13 (6), 475-486, 2007
3942007
Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant
JD Douketis, AC Spyropoulos, J Duncan, M Carrier, G Le Gal, AJ Tafur, ...
JAMA internal medicine 179 (11), 1469-1478, 2019
3782019
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
AT Cohen, R Alikhan, JI Arcelus, JF Bergmann, S Haas, GJ Merli, ...
Thrombosis and haemostasis 94 (10), 750-759, 2005
3422005
系统目前无法执行此操作,请稍后再试。
文章 1–20